Balanced news tone
News Sentiment
AZN sentiment intelligence
AstraZeneca PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, -1.8% over four weeks, trend inactive, and near fair-value range.
AstraZeneca (AZN) Faces Changes Amid New U.S. Drug Tariff Regula
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
87/100 classification
One-week reaction
-2.1%
Price reacting lower
Trend fit
Trend inactive
-1.8% over four weeks
Fair value
5.6%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
17
Negative
7
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
AstraZeneca (AZN) Faces Changes Amid New U.S. Drug Tariff Regula
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 21 Jul 2026 23:32
- Source
- GuruFocus
Market source
Direct company coverage
Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Jul 2026 22:15
- Source
- Market source
PR Newswire
Direct company coverage
AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 16 Jul 2026 14:07
- Source
- PR Newswire
Market source
Direct company coverage
Attractive Growth Profile Positions AstraZeneca PLC (AZN) as an Investment Bet
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 13:14
- Source
- Market source
ChartMill
Direct company coverage
AZN News | ASTRAZENECA PLC (NYSE:AZN)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 00:04
- Source
- ChartMill
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Could Trade At A 46% Discount After Wainua Setback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 05:10
- Source
- Market source
Market source
Direct company coverage
Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- Market source
Investor's Business Daily
Direct company coverage
Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- Investor's Business Daily
The Independent
Direct company coverage
AstraZeneca sees stock market value slump by more than £20bn after drug setback
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- The Independent
Barron's
Direct company coverage
AstraZeneca and Ionis Stock Slump After Trial Miss Is an Overreaction
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- Barron's
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Weighs Strong Run Against Cash Flow And Earnings Valuation Models
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Market source
Fortune
Direct company coverage
AstraZeneca (AZN): Company Profile, Stock Price, News, Rankings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Fortune
Market source
Direct company coverage
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks (JAZZ:NASDAQ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
Bloomberg.com
Direct company coverage
AstraZeneca (AZN) Shares to Start Trading in US After Listing Upgrade
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 02 Feb 2026 08:00
- Source
- Bloomberg.com
AstraZeneca
Direct company coverage
AstraZeneca begins trading on the New York Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- AstraZeneca
Stock Titan
Direct company coverage
AstraZeneca (NYSE: AZN) begins NYSE trading under harmonised global listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2026 08:00
- Source
- Stock Titan
Business Weekly
Direct company coverage
AstraZeneca wolfs down Wall Street listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Feb 2026 08:00
- Source
- Business Weekly
marketscreener.com
Direct company coverage
Swedish Stocks in North America – AstraZeneca Drops 0.8 Percent
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Dec 2025 08:00
- Source
- marketscreener.com
Morningstar
Direct company coverage
AstraZeneca Earnings: Momentum Continues Across Growth Franchises
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 Nov 2025 08:00
- Source
- Morningstar
WSJ
Direct company coverage
AstraZeneca to List Shares Directly on New York Stock Exchange
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- WSJ
Euronews.com
Direct company coverage
AstraZeneca to list shares in New York, without leaving the UK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Sep 2025 07:00
- Source
- Euronews.com
Reuters
Direct company coverage
AstraZeneca shares down 3% after rating cut, UK investment pause
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 15 Sep 2025 07:00
- Source
- Reuters
Morningstar
Direct company coverage
Stock of the Week: Are AstraZeneca Shares a Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Aug 2025 07:00
- Source
- Morningstar